Major M&A Bookends Year Of Mainly Steady Growth For Leading Medtech Groups

Dec 13 2018

Listen to this article

In Vivo's latest rankings of the top 100 revenue earners in the medical technology industry show the groups leading the global market tightening their grip further in 2017. This was partly a function of providers choosing to partner more and more with fewer suppliers who can offer a wider provision of services. But it was steady as she goes for most of the multinational medtechs, with some major exceptions, and there will be more M&A reflected in next year's rankings, based on 2018 revenues.

For companies leading the global medical technology industry, the sales rankings this year were strikingly similar to the last – with a handful of major exceptions – two of which affected the leading 10 global companies. These 10 companies all recorded sales of over $10 billion, with the acquisitive Boston Scientific Corp. (electrophysiology company Apama Medical being its only major buy in 2017) now knocking on the door of that exclusive club after seriously adding to its sales mix with a string of strategic buys in 2018.

Medtronic PLC led the field in terms of sales once more in 2017, but did not quite become history's...

Big Three Lead From The Front With Medtech Back On Solid Growth Footing

Dec 13 2022

• By Ashley Yeo

Abbott Laboratories and Johnson & Johnson joined Medtronic in putting a clear distance between themselves and other global medtechs in the Top 10 by revenues for 2021. Post-COVID-19 procedure growth, and, for Abbott, a strong rebound in non-COVID diagnostic demand, were key drivers.

Infographic: Top 100 Pharma Companies

Dec 13 2022

• By Lucie Ellis-Taitt

The Scrip 100 universe gathers FY2021 financial performance data and compares the activities of the top 100 biopharma businesses, ranked by pharma sales.

Pfizer Leads An Unusual Year For The Scrip 100

Dec 13 2022

• By Jessica Merrill

Pfizer catapulted back into the lead in the pharmaceutical rankings on the strength of COVID-19 revenues while BioNTech and Moderna both made the list for the first time.

Outlook 2023: The Pharma Rollercoaster Shows No Signs Of Slowing Down

Dec 12 2022

• By Jo Shorthouse

What will 2023 bring as the industry faces one of the toughest periods in the last decade? In Vivo asked three industry experts for their views.

Scrip 100: By The Numbers

Dec 06 2023

• By Lucie Ellis-Taitt and Kosh Naran

Pfizer dominated the Scrip 100 rankings of the top pharmaceutical companies in the world based on full year 2022 pharmaceutical sales, driven by its COVID-19 success.